UiPath (PATH) 10-Q 2 Jun 23 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Apr. 30, 2023	May 30, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--01-31
Entity Filer Category	Large Accelerated Filer
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		478,709,485
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 1,311,576	$ 1,402,119
Marketable securities	469,071	354,774
Accounts receivable, net of allowance for credit losses of $1,017 and $2,698, respectively	233,307	374,217
Contract assets	68,536	69,260
Deferred contract acquisition costs	53,355	49,887
Prepaid expenses and other current assets	121,429	94,150
Total current assets	2,257,274	2,344,407
Marketable securities, non-current	5,710	2,942
Contract assets, non-current	6,930	6,523
Deferred contract acquisition costs, non-current	136,571	137,616
Property and equipment, net	26,911	29,045
Operating lease right-of-use assets	52,275	52,052
Intangible assets, net	21,167	23,010
Goodwill	89,207	88,010
Deferred tax asset	5,915	5,895
Other assets, non-current	40,723	45,706
Total assets	2,642,683	2,735,206
Current liabilities
Accounts payable	5,734	8,891
Accrued expenses and other current liabilities	63,138	76,645
Accrued compensation and employee benefits	48,622	142,582
Deferred revenue	385,895	398,334
Total current liabilities	503,389	626,452
Deferred revenue, non-current	113,222	121,697
Operating lease liabilities, non-current	56,564	56,442
Other liabilities, non-current	13,971	10,457
Total liabilities	687,146	815,048
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized as of April 30, 2023 and January 31, 2023; 0 shares issued and outstanding as of April 30, 2023 and January 31, 2023	0	0
Additional paid-in capital	3,801,656	3,736,838
Accumulated other comprehensive income	10,074	7,612
Accumulated deficit	(1,856,199)	(1,824,298)
Total stockholders’ equity	1,955,537	1,920,158
Total liabilities and stockholders’ equity	2,642,683	2,735,206
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Accounts receivable, allowance for doubtful accounts	$ 1,017	$ 2,698
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	478,122	474,160
Common stock, shares outstanding (in shares)	478,122	474,160
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Revenue:
Total revenue	$ 289,588	$ 245,066
Cost of revenue:
Total cost of revenue	43,667	45,016
Gross profit	245,921	200,050
Operating expenses:
Sales and marketing	160,406	189,782
Research and development	75,342	68,690
General and administrative	56,584	57,530
Total operating expenses	292,332	316,002
Operating loss	(46,411)	(115,952)
Interest income	13,848	991
Other income (expense), net	4,294	(2,811)
Loss before income taxes	(28,269)	(117,772)
Provision for income taxes	3,632	4,789
Net loss	$ (31,901)	$ (122,561)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.23)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.23)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	557,878	541,902
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	557,878	541,902
Licenses
Revenue:
Total revenue	$ 134,039	$ 117,004
Cost of revenue:
Total cost of revenue	2,547	2,537
Subscription services
Revenue:
Total revenue	146,352	115,494
Cost of revenue:
Total cost of revenue	23,078	21,045
Professional services and other
Revenue:
Total revenue	9,197	12,568
Cost of revenue:
Total cost of revenue	$ 18,042	$ 21,434

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (31,901)	$ (122,561)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	143	(460)
Foreign currency translation adjustments	2,319	2
Other comprehensive income (loss), net	2,462	(458)
Comprehensive loss	$ (29,439)	$ (123,019)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022				458,773	82,453
Beginning balance at Jan. 31, 2022	$ 1,921,917			$ 4	$ 1	$ 3,406,959	$ 10,899	$ (1,495,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,283
Issuance of common stock upon exercise of stock options	2,683					2,683
Vesting of early exercised stock options	1,355					1,355
Issuance of common stock upon settlement of restricted stock units (in shares)				3,499
Tax withholdings on settlement of restricted stock units (in shares)				(1,125)
Tax withholdings on settlement of restricted stock units	(24,827)					(24,827)
Stock-based compensation	102,085					102,085
Other comprehensive income (loss), net	(458)						(458)
Net loss	(122,561)	$ (103,914)	$ (18,647)					(122,561)
Ending balance (in shares) at Apr. 30, 2022				462,430	82,453
Ending balance at Apr. 30, 2022	1,880,194			$ 4	$ 1	3,488,255	10,441	(1,618,507)
Beginning balance (in shares) at Jan. 31, 2023		474,160	82,453	474,160	82,453
Beginning balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1	3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	898			898
Issuance of common stock upon exercise of stock options	$ 1,175					1,175
Issuance of common stock upon settlement of restricted stock units (in shares)				4,246
Tax withholdings on settlement of restricted stock units (in shares)				(1,463)
Tax withholdings on settlement of restricted stock units	(25,697)					(25,697)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215					4,215
Stock-based compensation	85,125					85,125
Other comprehensive income (loss), net	2,462						2,462
Net loss	(31,901)	$ (27,186)	$ (4,715)					(31,901)
Ending balance (in shares) at Apr. 30, 2023		478,122	82,453	478,122	82,453
Ending balance at Apr. 30, 2023	$ 1,955,537			$ 5	$ 1	$ 3,801,656	$ 10,074	$ (1,856,199)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities
Net loss	$ (31,901)	$ (122,561)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	5,616	4,039
Amortization of deferred contract acquisition costs	14,072	10,822
Net amortization on marketable securities	(4,097)	473
Stock-based compensation expense	85,048	101,454
Charitable donation of Class A common stock	4,215	0
Amortization of operating lease right-of-use assets	3,071	2,759
Provision for deferred income taxes	(267)	1,594
Other non-cash charges, net	624	2,849
Changes in operating assets and liabilities:
Accounts receivable	141,557	76,864
Contract assets	660	(18,523)
Deferred contract acquisition costs	(15,499)	(20,761)
Prepaid expenses and other assets	(5,860)	(5,231)
Accounts payable	(2,130)	7,554
Accrued expenses and other liabilities	(10,547)	(12,894)
Accrued compensation and employee benefits	(93,390)	(65,083)
Operating lease liabilities, net	(2,946)	(1,950)
Deferred revenue	(20,885)	(14,289)
Net cash provided by (used in) operating activities	67,341	(52,884)
Cash flows from investing activities
Purchases of marketable securities	(215,391)	(21,918)
Maturities of marketable securities	78,955	14,813
Purchases of property and equipment	(1,870)	(9,692)
Other investing, net	2,754	1,100
Net cash used in investing activities	(135,552)	(15,697)
Cash flows from financing activities
Proceeds from exercise of stock options	1,187	2,823
Payments of tax withholdings on net settlement of equity awards	(25,902)	(17,329)
Net payments of tax withholdings on sell-to-cover equity award transactions	(645)	(10,037)
Proceeds from employee stock purchase plan contributions	4,730	6,356
Net cash used in financing activities	(20,630)	(18,187)
Effect of exchange rate changes	(1,702)	(2,738)
Net decrease in cash and cash equivalents	(90,543)	(89,506)
Cash and cash equivalents - beginning of period	1,402,119	1,768,723
Cash and cash equivalents - end of period	1,311,576	1,679,217
Supplemental disclosure of cash flow information
Cash paid for interest	86	277
Cash paid for income taxes	6,218	2,782
Supplemental disclosure of non-cash investing and financing activities
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options	0	1,355
Property and equipment purchases included in accounts payable	65	779
Receivable from maturities of marketable securities included in prepaid expense and other current assets	20,315	0
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	$ 1,996	$ 7,599

Organization and Description of

Organization and Description of Business	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our end-to-end automation platform, the UiPath Business Automation Platform, offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies , in the notes to consolidated financial statements included in the 2023 Form 10-K. There have been no significant changes to such policies during the three months ended April 30, 2023. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the three months ended April 30, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended April 30, 2023 and 2022, we recognized transaction losses of $0.8 million and $1.4 million, respectively. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2023 and January 31, 2023, 97% and 98%, respectively, of our cash and cash equivalents were concentrated in the United States, European Union (“EU”) countries, and Japan. We extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three months ended April 30, 2023 and 2022, no single customer accounted for 10% or more of our total revenue. As of April 30, 2023 and January 31, 2023, no single customer accounted for 10% or more of our accounts receivable.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended April 30, 2023 2022 Amount Percentage of Amount Percentage of Americas (1) $ 123,452 43 % $ 114,151 47 % Europe, Middle East, and Africa 96,931 33 % 69,603 28 % Asia-Pacific (2) 69,205 24 % 61,312 25 % Total revenue $ 289,588 100 % $ 245,066 100 % (1) Revenue from the United States represented 38% and 42% of total revenue for the three months ended April 30, 2023 and 2022, respectively. (2) Revenue from Japan represented 13% and 14% of total revenue for the three months ended April 30, 2023 and 2022, respectively. Deferred Revenue During the three months ended April 30, 2023 and 2022, we recognized $150.6 million and $124.9 million of revenue that was included in the deferred revenue balance as of January 31, 2023 and 2022, respectively . Remaining Performance Obligations Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of April 30, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $903.9 million, which consists of $499.1 million of billed consideration and $404.8 million of unbilled consideration. We expect to recognize 62% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter. Deferred Contract Acquisition Costs Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $14.1 million and $10.8 million for the three months ended April 30, 2023 and 2022, respectively, and is recorded in sal es and marketing expense in the condensed consolidated statements of operations.

Marketable Securities

Marketable Securities	3 Months Ended
	Apr. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The following is a summary of our marketable securities (in thousands): As of April 30, 2023 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 63,814 $ — $ — $ 63,814 Treasury bills and U.S. government securities 370,011 — (379) 369,632 Corporate bonds 24,968 — (35) 24,933 Municipal bonds 3,767 — (36) 3,731 Agency bonds 12,697 — (26) 12,671 Total marketable securities $ 475,257 $ — $ (476) $ 474,781 As of January 31, 2023 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 62,470 $ — $ — $ 62,470 Treasury bills and U.S. government securities (1) 234,848 — (308) 234,540 Corporate bonds 46,684 — (198) 46,486 Municipal bonds 6,374 — (66) 6,308 Agency bonds 7,959 — (47) 7,912 Total marketable securities $ 358,335 $ — $ (619) $ 357,716 (1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less. As of April 30, 2023 and January 31, 2023, respectively $5.7 million and $2.9 million of our marketable securities had remaining contractual maturities of one year or more, and the remainder had contractual maturities of less than one year. As of April 30, 2023 and January 31, 2023, $2.8 million and $3.5 million of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2023 and January 31, 2023. Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the

Fair Value Measurement

Fair Value Measurement	3 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2023 and January 31, 2023 (in thousands): As of April 30, 2023 Level 1 Level 2 Total Financial assets: Money market $ 612,577 $ — $ 612,577 Corporate bonds — 24,137 24,137 Commercial paper — 55,690 55,690 Agency bonds 5,667 — 5,667 Total cash equivalents 618,244 79,827 698,071 Commercial paper — 63,814 63,814 Treasury bills and U.S. government securities 369,632 — 369,632 Corporate bonds — 24,933 24,933 Municipal bonds — 3,731 3,731 Agency bonds 12,671 — 12,671 Total marketable securities 382,303 92,478 474,781 Total $ 1,000,547 $ 172,305 $ 1,172,852 As of January 31, 2023 Level 1 Level 2 Total Financial assets: Money market $ 319,801 $ — $ 319,801 Treasury bills 9,968 — 9,968 Total cash equivalents 329,769 — 329,769 Commercial paper — 62,470 62,470 Treasury bills and U.S. government securities 234,540 — 234,540 Corporate bonds — 46,486 46,486 Municipal bonds — 6,308 6,308 Agency bonds 7,912 — 7,912 Total marketable securities 242,452 115,264 357,716 Total $ 572,221 $ 115,264 $ 687,485 Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper, corporate bonds, and municipal bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of April 30, 2023 or January 31, 2023.

Business Acquisitions

Business Acquisitions	3 Months Ended
	Apr. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Business Acquisitions	Business Acquisitions Re:infer On July 29, 2022, we acquired all of the outstanding capital stock of Re:infer LTD. (“Re:infer”), a natural language processing company focused on unstructured documents and communications. Re:infer uses machine learning technology to mine context from communication messages and transform them into actionable data. With this acquisition, we gained technology and an experienced team which we believe will accelerate our technology roadmap, expand the breadth of our current AI-powered automation capabilities, and unlock new automation opportunities for our customers. The Re:infer acquisition was accounted for as a business combination. The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands): Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note to be paid on first anniversary of closing (included in accrued expenses and other current liabilities) 5,863 Loan note to be paid on second anniversary of closing (included in other liabilities, non-current) 5,570 Working capital adjustment 66 Total $ 44,581 At closing, we also issued an additional 0.4 million shares of Class A common stock that will be released to sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to certain employment-related clawback provisions. The aggregate fair value of these shares totaled $7.6 million and will be expensed as compensation for post-acquisition services over the three years following the acquisition date. The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands): July 29, 2022 Net tangible assets $ 300 Intangible assets 13,100 Goodwill 34,351 Total assets acquired 47,751 Deferred tax liabilities assumed (3,170) Total $ 44,581 The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Estimated Useful Life Developed technology $ 10,000 5.0 Customer relationships 3,100 3.0 Total $ 13,100 The acquisition of Re:infer generated goodwill of $34.4 million representing expected synergies and acquired skilled workforce. None of this goodwill is deductible for tax purposes.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets, Net Acquired intangible assets, net consisted of the following as of April 30, 2023 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 28,946 $ (12,705) $ 16,241 3.3 Customer relationships 8,249 (4,289) 3,960 1.8 Trade names and trademarks 273 (243) 30 0.9 Other intangibles 1,231 (295) 936 7.5 Total $ 38,699 $ (17,532) $ 21,167 Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 28,517 $ (11,095) $ 17,422 3.5 Customer relationships 8,174 (3,601) 4,573 2.0 Trade names and trademarks 272 (233) 39 1.2 Other intangibles 1,231 (255) 976 7.7 Total $ 38,194 $ (15,184) $ 23,010 We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended April 30, 2023 and 2022 was $2.1 million and $1.4 million, respectively. Expected future amortization expense related to intangible assets was as follows as of April 30, 2023 (in thousands): Amount Remainder of year ending January 31, 2024 $ 6,502 Year ending January 31, 2025 6,692 2026 4,084 2027 2,432 2028 1,155 Thereafter 302 Total $ 21,167 Goodwill Changes in the carrying amount of goodwill during the three months ended April 30, 2023 were as follows (in thousands): Carrying Balance as of January 31, 2023 $ 88,010 Effect of foreign currency translation 1,197 Balance as of April 30, 2023 $ 89,207

Operating Leases

Operating Leases	3 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Operating Leases	Operating Leases Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 15 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees. Lease costs are presented below (in thousands): Three Months Ended April 30, 2023 2022 Operating lease cost $ 3,071 $ 2,759 Short-term lease cost 1,300 1,508 Variable lease cost 621 207 Sublease income (1) (532) (532) Total $ 4,460 $ 3,942 (1) Included in other income (expense), net in the condensed consolidated statements of operations. The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of April 30, 2023 January 31, 2023 Weighted-average remaining lease term (years) 11.8 12.1 Weighted-average discount rate 7.1 % 7.0 % Future undiscounted lease payments for our operating lease liabilities as of April 30, 2023 were as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 10,008 Year ending January 31, 2025 10,215 2026 8,473 2027 7,957 2028 7,759 Thereafter 48,625 Total operating lease payments 93,037 Less: imputed interest (29,220) Total operating lease liabilities $ 63,817 As of April 30, 2023, we had non-cancellable commitments in the amount of $4.9 million related to operating leases of real estate facilities that have not yet commenced. Current operating lease liabilities of $7.3 million and $7.0 million were included in accrued expenses and other current liabilities Supplemental cash flow information related to leases for the three months ended April 30, 2023 and 2022 was as follows (in thousands): Three Months Ended April 30, 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 2,615 $ 2,064 Operating lease ROU assets obtained in exchange for new operating lease liabilities 1,993 770

Condensed Consolidated Balanc_3

Condensed Consolidated Balance Sheet Components	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Balance Sheet Components	Condensed Consolidated Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of April 30, 2023 January 31, 2023 Prepaid expenses and service credits $ 77,600 $ 67,794 Other current assets 43,829 26,356 Prepaid expenses and other current assets $ 121,429 $ 94,150 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of April 30, 2023 January 31, 2023 Computers and equipment $ 28,847 $ 28,450 Leasehold improvements 21,505 19,622 Furniture and fixtures 6,495 6,485 Construction in progress 572 2,419 Property and equipment, gross 57,419 56,976 Less: accumulated depreciation (30,508) (27,931) Property and equipment, net $ 26,911 $ 29,045 Depreciation expense for the three months ended April 30, 2023 and 2022 was $3.0 million and $1.9 million, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of April 30, 2023 January 31, 2023 Accrued expenses $ 14,089 $ 19,411 Withholding tax from employee equity transactions 2,132 3,772 Employee stock purchase plan withholdings 8,121 3,365 Payroll taxes and other benefits payable 4,106 7,644 Income tax payable 6,317 8,750 Value-added taxes payable 3,528 6,381 Operating lease liabilities, current 7,253 6,997 Deferred consideration for business acquisition, current 5,863 5,863 Other 11,729 14,462 Accrued expenses and other current liabilities $ 63,138 $ 76,645

Credit Facility

Credit Facility	3 Months Ended
	Apr. 30, 2023
Debt Disclosure [Abstract]
Credit Facility	Credit Facility On October 30, 2020, we entered into a $200.0 million senior secured revolving credit facility (the “Credit Facility”) with HSBC Ventures USA Inc., Silicon Valley Bridge Bank, N.A. (as successor to Silicon Valley Bank), Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD, maturing October 30, 2023. The Credit Facility contains certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions. We may use the proceeds of future borrowings under the Credit Facility for refinancing other indebtedness, working capital, capital expenditures and other general corporate purposes, including permitted business acquisitions. Our obligations under the Credit Facility are secured by substantially all of our assets, except for our intellectual property. As of April 30, 2023 and January 31, 2023, there were no amounts outstanding under the Credit Facility.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit We had a total of $5.6 million and $4.3 million in letters of credit outstanding in favor of certain landlords for office space and for credit line facilities as of April 30, 2023 and January 31, 2023, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2025. Indemnification In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of April 30, 2023 and January 31, 2023, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote. Restructuring On June 24, 2022, our board of directors approved restructuring actions to manage our operating expenses by reducing our global workforce by approximately 5%. The workforce reduction aimed to simplify our go-to-market approach and improve sales productivity. In connection with these workforce reductions, we also ceased use of our office in Brooklyn, NY. On November 10, 2022, our board of directors approved further restructuring actions to reduce our global workforce across functions by an additional 6%. We substantially completed these actions and recognized related restructuring costs, consisting predominantly of employee termination benefits and contractual changes, during fiscal year 2023, with the remaining activities expected to be completed by July 31, 2023. For the three months ended April 30, 2023, we incurred $0.9 million of expense associated with our restructuring actions, which relates to employee termination benefits. The following table shows the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of April 30, 2023 (in thousands): Employee Termination Benefits Accrued restructuring costs as of January 31, 2023 $ 3,889 Restructuring costs incurred during the three months ended April 30, 2023 889 Amount paid during the three months ended April 30, 2023 (3,734) Accrued restructuring costs as of April 30, 2023 $ 1,044 Defined Contribution Plans We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans was $5.6 million and $5.0 million for the three months ended April 30, 2023 and 2022, respectively. Litigation From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters, which arise in the ordinary course of business. In accordance with Accounting Standards Codification ("ASC") 450, Contingencies , we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. We are not presently a party to any litigation the outcome of which we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows, or financial condition. We have determined that the existence of a material loss is neither probable nor reasonably possible. Warranty We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made. Non-Cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and service credits toward products and services from strategic alliance partners. As of April 30, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 52,760 Year ending January 31, 2025 101,556 2026 55,768 2027 20,271 2028 8,245 Thereafter — Total $ 238,600

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Apr. 30, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Charitable Donations of Class A Common Stock We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. During the three months ended April 30, 2023, we contributed 0.3 million shares of our Class A common stock to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair value of the shares on the contribution date of $4.2 million was recorded within general and administrative expense in the condensed consolidated statements of operations. Accumulated Other Comprehensive Income (Loss) For the three months ended April 30, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive income, net of tax 2,319 143 2,462 Balance as of April 30, 2023 $ 10,550 $ (476) $ 10,074 Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive income (loss), net of tax 2 (460) (458) Balance as of April 30, 2022 $ 11,236 $ (795) $ 10,441

Equity Incentive Plans and Stoc

Equity Incentive Plans and Stock-Based Compensation	3 Months Ended
	Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans and Stock-Based Compensation	Equity Incentive Plans and Stock-Based Compensation 2021 Stock Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards ("RSAs"), restricted stock units ("RSUs"), performance awards, and other forms of awards. As of April 30, 2023, we have reserved 173.7 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase. 2021 Employee Stock Purchase Plan In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of April 30, 2023, the ESPP authorizes the issuance of 21.5 million shares of our Class A common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of each offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date. Stock Options Stock option activity during the three months ended April 30, 2023 was as follows: Stock Weighted- Weighted-Average Aggregate Outstanding as of January 31, 2023 13,898 $ 3.32 7.7 $ 169,324 Granted 2,276 $ 0.10 Exercised (898) $ 1.31 Forfeited (116) $ 1.34 Outstanding as of April 30, 2023 15,160 $ 2.97 7.6 $ 172,461 Vested and exercisable as of April 30, 2023 6,419 $ 2.15 5.7 $ 76,588 The weighted-average grant date fair value of stock options granted during the three months ended April 30, 2023 was $16.51 per share. The intrinsic value of stock options exercised during the three months ended April 30, 2023 was $13.5 million. Unrecognized compensation expense associated with unvested stock options granted and outstanding as of April 30, 2023, was $142.6 million, which is to be recognized over a weighted-average remaining period of 2.6 years. Restricted Stock Units RSU activity during the three months ended April 30, 2023 was as follows: RSUs (in thousands) Weighted-Average Grant Unvested as of January 31, 2023 36,785 $ 22.48 Granted 11,914 $ 16.58 Vested (1) (4,181) $ 21.56 Forfeited (3,308) $ 24.65 Unvested as of April 30, 2023 41,210 $ 20.70 (1) Class A common stock has not been issued in connection with 77 vested RSUs because such RSUs were unsettled as of April 30, 2023. The vesting date fair value of RSUs that vested during the three months ended April 30, 2023 was $73.1 million. As of April 30, 2023, total unrecognized compensation expense related to unvested RSUs was approximately $751.5 million, which is to be recognized over a weighted-average remaining period of 2.7 years. Restricted Stock Awards In September 2020, we issued approximately 0.1 million RSAs to a member of our board of directors at a grant date fair value of $33.22 per share, totaling $4.0 million. Such RSAs vest monthly over four years from the grant date. The unvested shares are subject to a repurchase right held by us. As of April 30, 2023, total unrecognized compensation expense related to unvested RSAs was $1.4 million and will be recognized over the remaining vesting period of 1.4 years. Employee Stock Purchase Plan Awards As of April 30, 2023, total unrecognized compensation expense related to the ESPP was approximately $0.9 million, which is to be recognized over a weighted-average remaining period of 0.1 years. Stock-Based Compensation Associated with Business Acquisition At the closing of the acquisition of Re:infer on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) that will be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of April 30, 2023, total unrecognized compensation expense related to these shares was $5.7 million, which is to be recognized over a weighted-average remaining period of 2.3 years. Stock-Based Compensation Expense Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended April 30, 2023 2022 Cost of subscription services revenue $ 3,178 $ 3,216 Cost of professional services and other revenue 2,699 3,874 Sales and marketing 33,123 50,758 Research and development 24,773 26,623 General and administrative 21,275 16,983 Total $ 85,048 $ 101,454

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. We had a provision for income taxes of $3.6 million and $4.8 million for the three months ended April 30, 2023 and 2022, respectively. Our effective tax rate was (12.8%) and (4.1%) for the three months ended April 30, 2023 and 2022, respectively. For the three months ended April 30, 2023 and 2022, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the United States and foreign countries. The realization of tax benefits of net deferred tax assets (“DTAs”) is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the three months ended April 30, 2023, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. may not be realized. Accordingly, we recorded a full valuation allowance against the U.S., Romania, and the U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of April 30, 2023, there is no valuation allowance recorded against DTAs associated with Japan as we believe it is more likely than not that we will realize such assets during the prescribed statutory period. As of April 30, 2023, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $1.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. The tax positions of UiPath, Inc. and its subsidiaries are subject to income tax audits in multiple tax jurisdictions globally, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. At this time, we do not expect any significant changes in the next 12 months.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Three Months Ended April 30, 2023 2022 Class A Class B Class A Class B Numerator: Net loss $ (27,186) $ (4,715) $ (103,914) $ (18,647) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 475,425 82,453 459,449 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.06) $ (0.23) $ (0.23) Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Three Months Ended April 30, 2023 2022 Class A Class B Class A Class B Unvested RSUs 37,351 — 27,271 — Outstanding stock options 13,883 — 13,786 — Shares subject to repurchase from RSAs and early exercised stock options 63 — 862 — Shares issuable under ESPP 897 — 1,035 — Returnable shares issued in connection with business acquisition 427 — — — Total weighted-average anti-dilutive common stock equivalents 52,621 — 42,954 —

Related Party Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Beginning in the third quarter of fiscal year 2022, we have at times made use of an aircraft which is owned by Daniel Dines, our Co-Chief Executive Officer, through a special purpose limited liability company and which is operated by a third-party aircraft management company. Mr. Dines, through the special purpose limited liability company, obtained financing for the aircraft and bears all associated operating, personnel, and maintenance costs. We did not incur any expense related to use of the aircraft for the three months ended April 30, 2023. For the three months ended April 30, 2022, we incurred expenses of $0.8 million in connection with our business use of the aircraft.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2023, which are included in the 2023 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the three months ended April 30, 2023 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2024 or for any other future interim or annual period.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2024, for example, refer to the fiscal year ending January 31, 2024.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition including changes in variable consideration, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign CurrencyThe functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations.
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2023 and January 31, 2023, 97% and 98%, respectively, of our cash and cash equivalents were concentrated in the United States, European Union (“EU”) countries, and Japan. We extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue by Geographical Region	The following tables summarize revenue by geographical region (dollars in thousands): Three Months Ended April 30, 2023 2022 Amount Percentage of Amount Percentage of Americas (1) $ 123,452 43 % $ 114,151 47 % Europe, Middle East, and Africa 96,931 33 % 69,603 28 % Asia-Pacific (2) 69,205 24 % 61,312 25 % Total revenue $ 289,588 100 % $ 245,066 100 % (1) Revenue from the United States represented 38% and 42% of total revenue for the three months ended April 30, 2023 and 2022, respectively. (2) Revenue from Japan represented 13% and 14% of total revenue for the three months ended April 30, 2023 and 2022, respectively.

Marketable Securities (Tables)

Marketable Securities (Tables)	3 Months Ended
	Apr. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	The following is a summary of our marketable securities (in thousands): As of April 30, 2023 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 63,814 $ — $ — $ 63,814 Treasury bills and U.S. government securities 370,011 — (379) 369,632 Corporate bonds 24,968 — (35) 24,933 Municipal bonds 3,767 — (36) 3,731 Agency bonds 12,697 — (26) 12,671 Total marketable securities $ 475,257 $ — $ (476) $ 474,781 As of January 31, 2023 Amortized Cost Gross Gross Estimated Fair Value Commercial paper $ 62,470 $ — $ — $ 62,470 Treasury bills and U.S. government securities (1) 234,848 — (308) 234,540 Corporate bonds 46,684 — (198) 46,486 Municipal bonds 6,374 — (66) 6,308 Agency bonds 7,959 — (47) 7,912 Total marketable securities $ 358,335 $ — $ (619) $ 357,716 (1) Treasury bills with both amortized cost and estimated fair value of $10.0 million are included in cash and cash equivalents due to their original maturity of three months or less.

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis	The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2023 and January 31, 2023 (in thousands): As of April 30, 2023 Level 1 Level 2 Total Financial assets: Money market $ 612,577 $ — $ 612,577 Corporate bonds — 24,137 24,137 Commercial paper — 55,690 55,690 Agency bonds 5,667 — 5,667 Total cash equivalents 618,244 79,827 698,071 Commercial paper — 63,814 63,814 Treasury bills and U.S. government securities 369,632 — 369,632 Corporate bonds — 24,933 24,933 Municipal bonds — 3,731 3,731 Agency bonds 12,671 — 12,671 Total marketable securities 382,303 92,478 474,781 Total $ 1,000,547 $ 172,305 $ 1,172,852 As of January 31, 2023 Level 1 Level 2 Total Financial assets: Money market $ 319,801 $ — $ 319,801 Treasury bills 9,968 — 9,968 Total cash equivalents 329,769 — 329,769 Commercial paper — 62,470 62,470 Treasury bills and U.S. government securities 234,540 — 234,540 Corporate bonds — 46,486 46,486 Municipal bonds — 6,308 6,308 Agency bonds 7,912 — 7,912 Total marketable securities 242,452 115,264 357,716 Total $ 572,221 $ 115,264 $ 687,485

Business Acquisitions (Tables)

Business Acquisitions (Tables)	3 Months Ended
	Apr. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Total Purchase Consideration	The total purchase consideration for the acquisition of Re:infer was $44.6 million, consisting of the following (in thousands): Cash paid at closing $ 30,117 Fair value of Class A common stock issued at closing (0.2 million shares) 2,965 Loan note to be paid on first anniversary of closing (included in accrued expenses and other current liabilities) 5,863 Loan note to be paid on second anniversary of closing (included in other liabilities, non-current) 5,570 Working capital adjustment 66 Total $ 44,581
Schedule of Fair Values of Assets Acquired and Liabilities Assumed	The following table summarizes the fair values of the assets acquired and liabilities assumed as of the acquisition date (in thousands): July 29, 2022 Net tangible assets $ 300 Intangible assets 13,100 Goodwill 34,351 Total assets acquired 47,751 Deferred tax liabilities assumed (3,170) Total $ 44,581
Schedule of Identifiable Intangible Assets Acquired and Their Estimated Useful Lives	The following table sets forth the identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Estimated Useful Life Developed technology $ 10,000 5.0 Customer relationships 3,100 3.0 Total $ 13,100

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Acquired intangible assets, net consisted of the following as of April 30, 2023 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 28,946 $ (12,705) $ 16,241 3.3 Customer relationships 8,249 (4,289) 3,960 1.8 Trade names and trademarks 273 (243) 30 0.9 Other intangibles 1,231 (295) 936 7.5 Total $ 38,699 $ (17,532) $ 21,167 Acquired intangible assets, net consisted of the following as of January 31, 2023 (dollars in thousands): Intangible Assets, Accumulated Intangible Weighted- Developed technology $ 28,517 $ (11,095) $ 17,422 3.5 Customer relationships 8,174 (3,601) 4,573 2.0 Trade names and trademarks 272 (233) 39 1.2 Other intangibles 1,231 (255) 976 7.7 Total $ 38,194 $ (15,184) $ 23,010
Schedule of Expected Future Amortization Expenses Related to Intangible Assets	Expected future amortization expense related to intangible assets was as follows as of April 30, 2023 (in thousands): Amount Remainder of year ending January 31, 2024 $ 6,502 Year ending January 31, 2025 6,692 2026 4,084 2027 2,432 2028 1,155 Thereafter 302 Total $ 21,167
Schedule of Changes in Carrying Amounts of Goodwill	Changes in the carrying amount of goodwill during the three months ended April 30, 2023 were as follows (in thousands): Carrying Balance as of January 31, 2023 $ 88,010 Effect of foreign currency translation 1,197 Balance as of April 30, 2023 $ 89,207

Operating Leases (Tables)

Operating Leases (Tables)	3 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Schedule of Lease Costs and Supplemental Cash Flow Information	Lease costs are presented below (in thousands): Three Months Ended April 30, 2023 2022 Operating lease cost $ 3,071 $ 2,759 Short-term lease cost 1,300 1,508 Variable lease cost 621 207 Sublease income (1) (532) (532) Total $ 4,460 $ 3,942 (1) Included in other income (expense), net in the condensed consolidated statements of operations. Supplemental cash flow information related to leases for the three months ended April 30, 2023 and 2022 was as follows (in thousands): Three Months Ended April 30, 2023 2022 Cash paid for amounts included in the measurement of operating lease liabilities $ 2,615 $ 2,064 Operating lease ROU assets obtained in exchange for new operating lease liabilities 1,993 770
Schedule of Weighted-average Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate as of the periods presented: As of April 30, 2023 January 31, 2023 Weighted-average remaining lease term (years) 11.8 12.1 Weighted-average discount rate 7.1 % 7.0 %
Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities	Future undiscounted lease payments for our operating lease liabilities as of April 30, 2023 were as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 10,008 Year ending January 31, 2025 10,215 2026 8,473 2027 7,957 2028 7,759 Thereafter 48,625 Total operating lease payments 93,037 Less: imputed interest (29,220) Total operating lease liabilities $ 63,817

Condensed Consolidated Balanc_4

Condensed Consolidated Balance Sheet Components (Tables)	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of April 30, 2023 January 31, 2023 Prepaid expenses and service credits $ 77,600 $ 67,794 Other current assets 43,829 26,356 Prepaid expenses and other current assets $ 121,429 $ 94,150
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of April 30, 2023 January 31, 2023 Computers and equipment $ 28,847 $ 28,450 Leasehold improvements 21,505 19,622 Furniture and fixtures 6,495 6,485 Construction in progress 572 2,419 Property and equipment, gross 57,419 56,976 Less: accumulated depreciation (30,508) (27,931) Property and equipment, net $ 26,911 $ 29,045
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of April 30, 2023 January 31, 2023 Accrued expenses $ 14,089 $ 19,411 Withholding tax from employee equity transactions 2,132 3,772 Employee stock purchase plan withholdings 8,121 3,365 Payroll taxes and other benefits payable 4,106 7,644 Income tax payable 6,317 8,750 Value-added taxes payable 3,528 6,381 Operating lease liabilities, current 7,253 6,997 Deferred consideration for business acquisition, current 5,863 5,863 Other 11,729 14,462 Accrued expenses and other current liabilities $ 63,138 $ 76,645

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Accrued Restructuring Costs	The following table shows the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of April 30, 2023 (in thousands): Employee Termination Benefits Accrued restructuring costs as of January 31, 2023 $ 3,889 Restructuring costs incurred during the three months ended April 30, 2023 889 Amount paid during the three months ended April 30, 2023 (3,734) Accrued restructuring costs as of April 30, 2023 $ 1,044
Schedule of Non-Cancelable Purchase Obligations	As of April 30, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands): Amount Remainder of year ending January 31, 2024 $ 52,760 Year ending January 31, 2025 101,556 2026 55,768 2027 20,271 2028 8,245 Thereafter — Total $ 238,600

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2023
Equity [Abstract]
Schedule of Changes In Components of Accumulated Other Comprehensive Income (Loss)	For the three months ended April 30, 2023 and 2022, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands): Foreign Currency Translation Adjustments Unrealized Gain (Loss) on Marketable Securities Accumulated Other Comprehensive Income Balance as of January 31, 2023 $ 8,231 $ (619) $ 7,612 Other comprehensive income, net of tax 2,319 143 2,462 Balance as of April 30, 2023 $ 10,550 $ (476) $ 10,074 Foreign Currency Translation Adjustments Unrealized Loss on Marketable Securities Accumulated Other Comprehensive Income (Loss) Balance as of January 31, 2022 $ 11,234 $ (335) $ 10,899 Other comprehensive income (loss), net of tax 2 (460) (458) Balance as of April 30, 2022 $ 11,236 $ (795) $ 10,441

Equity Incentive Plans and St_2

Equity Incentive Plans and Stock-Based Compensation (Tables)	3 Months Ended
	Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	Stock option activity during the three months ended April 30, 2023 was as follows: Stock Weighted- Weighted-Average Aggregate Outstanding as of January 31, 2023 13,898 $ 3.32 7.7 $ 169,324 Granted 2,276 $ 0.10 Exercised (898) $ 1.31 Forfeited (116) $ 1.34 Outstanding as of April 30, 2023 15,160 $ 2.97 7.6 $ 172,461 Vested and exercisable as of April 30, 2023 6,419 $ 2.15 5.7 $ 76,588
Summary of RSU Activity	RSU activity during the three months ended April 30, 2023 was as follows: RSUs (in thousands) Weighted-Average Grant Unvested as of January 31, 2023 36,785 $ 22.48 Granted 11,914 $ 16.58 Vested (1) (4,181) $ 21.56 Forfeited (3,308) $ 24.65 Unvested as of April 30, 2023 41,210 $ 20.70 (1) Class A common stock has not been issued in connection with 77 vested RSUs because such RSUs were unsettled as of April 30, 2023.
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands): Three Months Ended April 30, 2023 2022 Cost of subscription services revenue $ 3,178 $ 3,216 Cost of professional services and other revenue 2,699 3,874 Sales and marketing 33,123 50,758 Research and development 24,773 26,623 General and administrative 21,275 16,983 Total $ 85,048 $ 101,454

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands except per share amounts): Three Months Ended April 30, 2023 2022 Class A Class B Class A Class B Numerator: Net loss $ (27,186) $ (4,715) $ (103,914) $ (18,647) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 475,425 82,453 459,449 82,453 Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.06) $ (0.23) $ (0.23)
Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share	Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share attributable to common stockholders were as follows (in thousands): Three Months Ended April 30, 2023 2022 Class A Class B Class A Class B Unvested RSUs 37,351 — 27,271 — Outstanding stock options 13,883 — 13,786 — Shares subject to repurchase from RSAs and early exercised stock options 63 — 862 — Shares issuable under ESPP 897 — 1,035 — Returnable shares issued in connection with business acquisition 427 — — — Total weighted-average anti-dilutive common stock equivalents 52,621 — 42,954 —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction losses	$ 0.8	$ 1.4
United States, European Union (“EU”) Countries, and Japan | Geographic Concentration Risk | Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	97%		98%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Amount	$ 289,588	$ 245,066
Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%
Americas
Disaggregation of Revenue [Line Items]
Amount	$ 123,452	$ 114,151
Americas | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	43%	47%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Amount	$ 96,931	$ 69,603
Europe, Middle East, and Africa | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	33%	28%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Amount	$ 69,205	$ 61,312
Asia-Pacific | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	24%	25%
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	38%	42%
Japan | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	13%	14%

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 150,600	$ 124,900
Deferred contract acquisition costs	$ 14,072	$ 10,822

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Apr. 30, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 903.9
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	499.1
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 404.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-05-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	62%
Remaining performance obligations, period	12 months

Marketable Securities - Summary

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 475,257	$ 358,335
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(476)	(619)
Estimated Fair Value	474,781	357,716
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	63,814	62,470
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	63,814	62,470
Treasury bills and U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	370,011	234,848
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(379)	(308)
Estimated Fair Value	369,632	234,540
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	24,968	46,684
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(35)	(198)
Estimated Fair Value	24,933	46,486
Municipal bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,767	6,374
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(36)	(66)
Estimated Fair Value	3,731	6,308
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	12,697	7,959
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(26)	(47)
Estimated Fair Value	$ 12,671	7,912
Cash and cash equivalents | Treasury bills
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		10,000
Estimated Fair Value		$ 10,000

Marketable Securities - Additio

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 5,710	$ 2,942
Prepaid Expenses and Other Current Assets
Debt Securities, Available-for-sale [Line Items]
Interest receivable	$ 2,800	$ 3,500

Fair Value Measurement (Details

Fair Value Measurement (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Financial assets:
Total marketable securities	$ 474,781	$ 357,716
Commercial paper
Financial assets:
Total marketable securities	63,814	62,470
Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	369,632	234,540
Corporate bonds
Financial assets:
Total marketable securities	24,933	46,486
Municipal bonds
Financial assets:
Total marketable securities	3,731	6,308
Agency bonds
Financial assets:
Total marketable securities	12,671	7,912
Recurring
Financial assets:
Total cash equivalents	698,071	329,769
Total marketable securities	474,781	357,716
Total	1,172,852	687,485
Recurring | Commercial paper
Financial assets:
Total marketable securities	63,814	62,470
Recurring | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	369,632	234,540
Recurring | Corporate bonds
Financial assets:
Total marketable securities	24,933	46,486
Recurring | Municipal bonds
Financial assets:
Total marketable securities	3,731	6,308
Recurring | Agency bonds
Financial assets:
Total marketable securities	12,671	7,912
Recurring | Money market
Financial assets:
Total cash equivalents	612,577	319,801
Recurring | Corporate bonds
Financial assets:
Total cash equivalents	24,137
Recurring | Commercial paper
Financial assets:
Total cash equivalents	55,690
Recurring | Agency bonds
Financial assets:
Total cash equivalents	5,667
Recurring | Treasury bills
Financial assets:
Total cash equivalents		9,968
Recurring | Level 1
Financial assets:
Total cash equivalents	618,244	329,769
Total marketable securities	382,303	242,452
Total	1,000,547	572,221
Recurring | Level 1 | Commercial paper
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	369,632	234,540
Recurring | Level 1 | Corporate bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Municipal bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 1 | Agency bonds
Financial assets:
Total marketable securities	12,671	7,912
Recurring | Level 1 | Money market
Financial assets:
Total cash equivalents	612,577	319,801
Recurring | Level 1 | Corporate bonds
Financial assets:
Total cash equivalents	0
Recurring | Level 1 | Commercial paper
Financial assets:
Total cash equivalents	0
Recurring | Level 1 | Agency bonds
Financial assets:
Total cash equivalents	5,667
Recurring | Level 1 | Treasury bills
Financial assets:
Total cash equivalents		9,968
Recurring | Level 2
Financial assets:
Total cash equivalents	79,827	0
Total marketable securities	92,478	115,264
Total	172,305	115,264
Recurring | Level 2 | Commercial paper
Financial assets:
Total marketable securities	63,814	62,470
Recurring | Level 2 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	0	0
Recurring | Level 2 | Corporate bonds
Financial assets:
Total marketable securities	24,933	46,486
Recurring | Level 2 | Municipal bonds
Financial assets:
Total marketable securities	3,731	6,308
Recurring | Level 2 | Agency bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 2 | Money market
Financial assets:
Total cash equivalents	0	0
Recurring | Level 2 | Corporate bonds
Financial assets:
Total cash equivalents	24,137
Recurring | Level 2 | Commercial paper
Financial assets:
Total cash equivalents	55,690
Recurring | Level 2 | Agency bonds
Financial assets:
Total cash equivalents	0
Recurring | Level 2 | Treasury bills
Financial assets:
Total cash equivalents		0
Recurring | Level 3
Financial assets:
Total	$ 0	$ 0

Business Acquisitions - Summary

Business Acquisitions - Summary of Total Purchase Consideration (Details) - Re:infer $ in Thousands, shares in Millions	Jul. 29, 2022 USD ($) shares
Business Acquisition [Line Items]
Cash paid at closing	$ 30,117
Fair value of Class A common stock issued at closing	2,965
Working capital adjustment	66
Total purchase consideration	$ 44,581
Stock issued at closing (in shares) | shares	0.2
Accrued expenses and other current liabilities
Business Acquisition [Line Items]
Loan note to be paid	$ 5,863
Other liabilities, non-current
Business Acquisition [Line Items]
Loan note to be paid	$ 5,570

Business Acquisitions - Additio

Business Acquisitions - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions		3 Months Ended
	Jul. 29, 2022	Apr. 30, 2023	Jan. 31, 2023
Business Acquisition [Line Items]
Purchase price allocation to goodwill		$ 89,207	$ 88,010
Re:infer
Business Acquisition [Line Items]
Total purchase consideration	$ 44,581
Stock issued at closing subject to clawback provisions (in shares)	0.4
Purchase price allocation to goodwill	$ 34,351
Goodwill deductible for tax purposes		0
Re:infer | Common Stock
Business Acquisition [Line Items]
Unrecognized compensation expense	$ 7,600	$ 5,700
Weighted-average remaining period	3 years	2 years 3 months 18 days

Business Acquisitions - Summa_2

Business Acquisitions - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023	Jul. 29, 2022
Business Acquisition [Line Items]
Goodwill	$ 89,207	$ 88,010
Re:infer
Business Acquisition [Line Items]
Net tangible assets			$ 300
Intangible assets			13,100
Goodwill			34,351
Total assets acquired			47,751
Deferred tax liabilities assumed			(3,170)
Total			$ 44,581

Business Acquisitions - Summa_3

Business Acquisitions - Summary of Components of Identifiable Intangible Assets Acquired and Their Estimated Useful Lives (Details) - Re:infer $ in Thousands	Jul. 29, 2022 USD ($)
Business Acquisition [Line Items]
Fair Value	$ 13,100
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 10,000
Estimated Useful Life	5 years
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 3,100
Estimated Useful Life	3 years

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 38,699	$ 38,194
Accumulated Amortization	(17,532)	(15,184)
Intangible Assets, Net	21,167	23,010
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,946	28,517
Accumulated Amortization	(12,705)	(11,095)
Intangible Assets, Net	$ 16,241	$ 17,422
Weighted- Average Remaining Useful Life (in years)	3 years 3 months 18 days	3 years 6 months
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,249	$ 8,174
Accumulated Amortization	(4,289)	(3,601)
Intangible Assets, Net	$ 3,960	$ 4,573
Weighted- Average Remaining Useful Life (in years)	1 year 9 months 18 days	2 years
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 273	$ 272
Accumulated Amortization	(243)	(233)
Intangible Assets, Net	$ 30	$ 39
Weighted- Average Remaining Useful Life (in years)	10 months 24 days	1 year 2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(295)	(255)
Intangible Assets, Net	$ 936	$ 976
Weighted- Average Remaining Useful Life (in years)	7 years 6 months	7 years 8 months 12 days

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 2.1	$ 1.4

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2024	$ 6,502
2025	6,692
2026	4,084
2027	2,432
2028	1,155
Thereafter	302
Intangible Assets, Net	$ 21,167	$ 23,010

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 88,010
Effect of foreign currency translation	1,197
Ending Balance	$ 89,207

Operating Leases - Additional I

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 4,900
Current operating lease liabilities	$ 7,253	$ 6,997
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	15 years

Operating Leases - Summary of L

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating lease cost	$ 3,071	$ 2,759
Short-term lease cost	1,300	1,508
Variable lease cost	621	207
Sublease income	(532)	(532)
Total	$ 4,460	$ 3,942

Operating Leases - Weighted Ave

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Apr. 30, 2023	Jan. 31, 2023
Leases [Abstract]
Weighted-average remaining lease term (years)	11 years 9 months 18 days	12 years 1 month 6 days
Weighted-average discount rate	7.10%	7%

Operating Leases - Summary of F

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Apr. 30, 2023 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2024	$ 10,008
2025	10,215
2026	8,473
2027	7,957
2028	7,759
Thereafter	48,625
Total operating lease payments	93,037
Less: imputed interest	(29,220)
Total operating lease liabilities	$ 63,817

Operating Leases - Supplemental

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 2,615	$ 2,064
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 1,993	$ 770

Condensed Consolidated Balanc_5

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 77,600	$ 67,794
Other current assets	43,829	26,356
Prepaid expenses and other current assets	$ 121,429	$ 94,150

Condensed Consolidated Balanc_6

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 57,419	$ 56,976
Less: accumulated depreciation	(30,508)	(27,931)
Property and equipment, net	26,911	29,045
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	28,847	28,450
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	21,505	19,622
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,495	6,485
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 572	$ 2,419

Condensed Consolidated Balanc_7

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 3	$ 1.9

Condensed Consolidated Balanc_8

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 14,089	$ 19,411
Withholding tax from employee equity transactions	2,132	3,772
Employee stock purchase plan withholdings	8,121	3,365
Payroll taxes and other benefits payable	4,106	7,644
Income tax payable	6,317	8,750
Value-added taxes payable	3,528	6,381
Operating lease liabilities, current	7,253	6,997
Deferred consideration for business acquisition, current	5,863	5,863
Other	11,729	14,462
Accrued expenses and other current liabilities	$ 63,138	$ 76,645

Credit Facility (Details)

Credit Facility (Details) - Senior Secured Credit Facility - HSBC Ventures USA Inc., Silicon Valley Bank, Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD - USD ($)	Apr. 30, 2023	Jan. 31, 2023	Oct. 30, 2020
Line of Credit Facility [Line Items]
Maximum borrowing capacity under credit agreement			$ 200,000,000
Outstanding liability under credit facility	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023	Nov. 10, 2022	Jun. 24, 2022
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 5,600		$ 4,300
Defined contribution plan, contribution cost	5,600	$ 5,000
Employee Termination Benefits
Restructuring Cost and Reserve [Line Items]
Expected percentage reduction of global workforce				6%	5%
Restructuring costs incurred	$ 889

Commitments and Contingencies_2

Commitments and Contingencies - Accrued Restructuring Costs (Details) - Employee Termination Benefits $ in Thousands	3 Months Ended
	Apr. 30, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Accrued restructuring costs, beginning balance	$ 3,889
Restructuring costs incurred	889
Amount paid	(3,734)
Accrued restructuring costs, ending balance	$ 1,044

Commitments and Contingencies_3

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Apr. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2024	$ 52,760
2025	101,556
2026	55,768
2027	20,271
2028	8,245
Thereafter	0
Total	$ 238,600

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Class of Stock [Line Items]
Charitable contribution recorded as expense	$ 4,215	$ 0
Class A Common Stock
Class of Stock [Line Items]
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)	2,800
Class A Common Stock | Common Stock
Class of Stock [Line Items]
Charitable donation of Class A common stock (in shares)	281

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Changes In Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 1,920,158	$ 1,921,917
Other comprehensive income (loss), net of tax	2,462	(458)
Ending balance	1,955,537	1,880,194
Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	7,612	10,899
Other comprehensive income (loss), net of tax	2,462	(458)
Ending balance	10,074	10,441
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,231	11,234
Other comprehensive income (loss), net of tax	2,319	2
Ending balance	10,550	11,236
Unrealized Gain (Loss) on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(619)	(335)
Other comprehensive income (loss), net of tax	143	(460)
Ending balance	$ (476)	$ (795)

Equity Incentive Plans and St_3

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		1 Months Ended		3 Months Ended
	Jul. 29, 2022	Apr. 22, 2021	Sep. 30, 2020	Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)				$ 16.51
Intrinsic value of stock options exercised				$ 13.5
Cost not yet recognized for unvested options				$ 142.6
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued at closing subject to clawback provisions (in shares)	0.4
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period				2 years 7 months 6 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period				2 years 8 months 12 days
Fair value of RSUs vested				$ 73.1
Unrecognized compensation expense				$ 751.5
Grant date fair value per share (in dollars per share)				$ 16.58
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period				1 year 4 months 24 days
Award vesting period			4 years
Unrecognized compensation expense				$ 1.4
Restricted stock awards issued (in shares)			0.1
Grant date fair value per share (in dollars per share)			$ 33.22
Restricted stock awards issued, value			$ 4
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)		15.5
Period of shares automatically increase		10 years
Percentage of total number of shares		1%
Number of shares authorized (in shares)		21.5
Weighted-average remaining period				1 month 6 days
Unrecognized compensation expense				$ 0.9
Common Stock | Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period	3 years			2 years 3 months 18 days
Unrecognized compensation expense	$ 7.6			$ 5.7
Class A Common Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price		85%
Purchase price of common stock, purchase date, percent of market price		85%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase		10 years
Percentage of total number of shares		5%
2021 Stock Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)				173.7

Equity Incentive Plans and St_4

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Stock Options
Outstanding, beginning balance (in shares)	13,898
Granted (in shares)	2,276
Exercised (in shares)	(898)
Forfeited (in shares)	(116)
Outstanding, ending balance (in shares)	15,160	13,898
Vested and exercisable, Number of Stock Options (in shares)	6,419
Weighted- Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 3.32
Granted (in dollars per share)	0.10
Exercised (in dollars per share)	1.31
Forfeited (in dollars per share)	1.34
Outstanding, ending balance (in dollars per share)	2.97	$ 3.32
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share)	$ 2.15
Outstanding, Weighted-Average Remaining Contractual Life (years)	7 years 7 months 6 days	7 years 8 months 12 days
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	5 years 8 months 12 days
Outstanding, Aggregate Intrinsic Value	$ 172,461	$ 169,324
Vested and exercisable, Aggregate Intrinsic Value	$ 76,588

Equity Incentive Plans and St_5

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	3 Months Ended
	Apr. 30, 2023 $ / shares shares
RSUs
Unvested, beginning balance (in shares)	36,785
Granted (in shares)	11,914
Vested (in shares)	(4,181)
Forfeited (in shares)	(3,308)
Unvested, ending balance (in shares)	41,210
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 22.48
Granted (in dollars per share) | $ / shares	16.58
Vested (in dollars per share) | $ / shares	21.56
Forfeited (in dollars per share) | $ / shares	24.65
Unvested, ending balance (in dollars per share) | $ / shares	$ 20.70
Class A Common Stock
Weighted-Average Grant Date Fair Value Per Share
Vested RSUs that were unsettled (in shares)	77

Equity Incentive Plans and St_6

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 85,048	$ 101,454
Cost of revenue | Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3,178	3,216
Cost of revenue | Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,699	3,874
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	33,123	50,758
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	24,773	26,623
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 21,275	$ 16,983

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Valuation Allowance [Line Items]
Provision for income taxes	$ 3,632	$ 4,789
Effective tax rate	(12.80%)	(4.10%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 2,300
Liability pertaining to uncertain tax positions	1,500
Japan
Valuation Allowance [Line Items]
Deferred tax valuation allowance	$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (31,901)	$ (122,561)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	557,878	541,902
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.23)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	557,878	541,902
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.23)
Class A Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (27,186)	$ (103,914)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	475,425	459,449
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.23)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	475,425	459,449
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.23)
Class B Common Stock
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (4,715)	$ (18,647)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	82,453	82,453
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.23)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	82,453	82,453
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.23)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	52,621	42,954
Class A Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	37,351	27,271
Class A Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	13,883	13,786
Class A Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	63	862
Class A Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	897	1,035
Class A Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	427	0
Class B Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0
Class B Common Stock | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0
Class B Common Stock | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0
Class B Common Stock | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0
Class B Common Stock | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0
Class B Common Stock | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents	0	0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Related Party Transaction [Line Items]
Operating expenses	$ 292,332	$ 316,002
Related Party | Use of Aircraft Owned by Co-Chief Executive Officer
Related Party Transaction [Line Items]
Operating expenses	$ 0	$ 800